There is considerable evidence that vascular endothelial growth factor
is involved in the vascularization and growth of primary tumors and i
n the formation of metastases. The expression of vascular endothelial
growth factor depends on activated oncogenes and inactivated tumor-sup
pressor genes as well as several other factors, e.g., growth actors, h
ypoxia, and tumor promoters. Substantial expression of vascular endoth
elial growth factor receptors is mainly restricted to tumor vessels. T
he causal involvement of this angiogenic factor in the progression of
the disease has been successfully evaluated using monoclonal antibodie
s against vascular endothelial growth factor, dominant negative recept
or mutants, and antisense oligonucleotides against the messenger RNA o
f vascular endothelial growth factor Thus, the vascular endothelial gr
owth factor-signaling system seems to be an appropriate target for inh
ibition of tumor angiogenesis and metastasis formation.